Skip to main content
. 2018 May 17;16(1):29–36. doi: 10.3892/etm.2018.6182

Table I.

Proportion of HeLa cells in G1, S and G2 phases of the cell cycle following ellagic acid treatment.

Ellagic acid dose µM

Cell cycle phase Control 10 20 30
G1 60.3±4.21   69.9±3.55a   75.7±3.27a 84.7±3.01a
S 8.44±0.39 9.65±0.61 8.71±0.41 7.56±0.37
G2 31.2±3.82 20.4±2.94a   15.6±2.87a   9.38±1.37a
a

P<0.05 vs. the control group. All data are expressed as the mean ± standard deviation.